Subscribe to Feed

Products tagged with 'EGFR'

30 Item(s)

per page

Set Descending Direction
  1. Afatinib dimaleate

    Catalog No. A14985
    Quick View
    EGFR inhibitor
    Afatinib is an irreversible EGFR/HER2 inhibitor with an IC50 of 14 nM for in vitro potency against HER2. Learn More
  2. AG-1478 (Tyrphostin AG-1478)

    Catalog No. A11022
    Quick View
    EGFR Inhibitor
    AG-1478 (Tyrphostin AG-1478) is an inhibitor of EGFR kinase with an IC50 value of 3 nM. Learn More
  3. AG-17

    Catalog No. A11949
    Quick View
    EGFR inhibitor
    AG-17 is an inhibitor of EGF receptor kinase with an IC50 value of 460 µM in the human epidermoid carcinoma cell line A431. Learn More
  4. AG-18 (Tyrphostin 23)

    Catalog No. A15940
    Quick View
    EGFR Inhibitor
    AG-18 is an inhibitor of epidermal growth factor (EGF) receptor kinase with an IC50 value of 35 ,M in the human epidermoid carcinoma cell line A431. Learn More
  5. AG-490

    Catalog No. A10047
    Quick View
    EGFR inhibitor
    AG 490 is a selective inhibitor of EGF receptor tyrosine kinase (IC50 values are 2 and 13.5 μM for EGFR and ErbB2 respectively). Also inhibits JAK2 with no activity to Lck, Lyn, Btk, Syk and Src. Learn More
  6. AZD-9291 (Osimertinib)

    Catalog No. A13681
    Quick View
    EGFR inhibitor
    AZD-9291 is a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors. Learn More
  7. AZD3759

    Catalog No. A15551
    Quick View
    EGFR inhibitor
    AZD3759 is an orally available inhibitor of the epidermal growth factor receptor (EGFR). It binds to and inhibits the activity of EGFR as well as certain mutant forms of EGFR. Learn More
  8. AZD8931 (Sapitinib)

    Catalog No. A10116
    Quick View
    pan-EGFR/pan-erbB inhibitor
    AZD8931 is an oral, equipotent inhibitor of ErbB1, ErbB2 and ErbB3 receptor signaling. Learn More
  9. BIBW2992 (Afatinib)

    Catalog No. A10141
    Quick View
    EGFR inhibitor
    BIBW2992 (Afatinib) is tyrosine kinase inhibitor (TKI) that irreversibly inhibits human epidermal growth factor receptor 2 (Her2) and epidermal growth factor receptor (EGFR) kinases. Learn More
  10. Biochanin A (4-Methylgenistein)

    Catalog No. A10146
    Quick View

    Biochanin A is an antiproliferative and anti-inflammatory agent that inhibits iNOS expression and lipopolysacharide (LPS)-induced nitric oxide production in macrophages. Additionally, Biochanin A displays the ability to block phosphorylation of IκBα and p38 MAPK, which prevents NF-κB activation. Furthermore, Biochanin A has been observed to suppress IL-6, IL-1β, and TNF-α production.

    Learn More
  11. Canertinib (CI-1033)

    Catalog No. A10211
    Quick View
    HER2/ErbB2 inhibitor
    Canertinib (CI-1033) is an irreversible tyrosine-kinase inhibitor with activity against EGFR (IC50 0.8 nM), HER-2 (IC50 19 nM) and ErbB-4 (IC50 7 nM). Learn More
  12. Chrysophanic acid (Chrysophanol)

    Catalog No. A10210
    Quick View
    EGFR inhibitor
    Chrysophanic acid (Chrysophanol) blocks proliferation of colon cancer cells by inhibiting EGFR/mTOR pathway. Learn More
  13. CL-387785 (EKI-785)

    Catalog No. A13146
    Quick View
    EGFR inhibitor
    CL-387785 is an irreversible inhibitor of EGFR with IC50 of 370+/-120 pM; is able to overcome resistance caused by the T790M mutation on a functional level. Learn More
  14. CNX-2006

    Catalog No. A13755
    Quick View
    EGFR inhibitor
    CNX-2006 is a potent, mutant-selective EGFR inhibitor with excellent in vitro activity in cells with activating EGFR mutations, as well as in cells harbouring the T790M mutation. CNX-2006 is the prototype for CO-1686, which is currently in a Phase I clinical trial for the treatment of EGFR-mutant lung cancer. Learn More
  15. CO-1686 (Rociletinib, AVL-301)

    Catalog No. A13028
    Quick View
    EGFR inhibitor
    CO-1686 is a novel, oral, targeted covalent (irreversible) inhibitor of the cancer-causing mutant forms of epidermal growth factor receptor (EGFR) currently being studied for the treatment of non-small cell lung cancer (NSCLC). Learn More
  16. Daphnetin

    Catalog No. A10286
    Quick View
    EGFR, PKA,PKC inhibitor
    Daphnetin is a coumarin analog that acts as an inhibitor of several protein kinases. It inhibits EGFR kinase (IC50 = 7.67 µM), PKA (IC50 = 9.33 µM), and PKC (IC50 = 25 µM), in vitro. The inhibition of EGFR kinase by daphnetin was competitive to ATP and non-competitive to the peptide substrate. Also acts as a potent antioxidant and anti-malarial agent. Learn More
  17. Erlotinib HCl

    Catalog No. A10362
    Quick View
    EGFR inhibitor
    Erlotinib hydrochloride is a reversible tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR). Learn More
  18. Icotinib

    Catalog No. A13825
    Quick View
    EGFR inhibitor
    Icotinib is a potent and specific EGFR inhibitor with IC50 of 5 nM, including the EGFR, EGFR(L858R), EGFR(L861Q), EGFR(T790M) and EGFR(T790M, L858R). Learn More
  19. Olmutinib (HM61713)

    Catalog No. A15976
    Quick View
    BTK inhibitor
    Olmutinib is a potent small molecule inhibitor of Bruton's tyrosine kinase (BTK). Learn More
  20. OSI-420

    Catalog No. A10678
    Quick View
    EGFR Inhibitor
    OSI-420 (Desmethyl Erlotinib,CP-473420) is an orally active EGFR tyrosin kinase inhibitor, which inhibits receptor tyrosine kinases (TKs) by inhibition of the intercellular domain . Learn More
  21. PD153035 (HCl salt)

    Catalog No. A10702
    Quick View
    EGFR inhibitor
    PD153035 is an extremely potent and specific inhibitor of the tyrosine kinase activity of EGFR. Learn More
  22. PD168393

    Catalog No. A12725
    Quick View
    EGFR inhibitor
    PD168393 is a potent, cell-permeable, irreversible inhibitor of EGFR with IC50 value of 700 pM. Learn More
  23. PF299804 (Dacomitinib, PF299)

    Catalog No. A11051
    Quick View
    EGFR inhibitor
    PF299804 is a potent, orally available, irreversible inhibitor of tyrosine kinase human epidermal growth factor receptors (HER) 1 (EGFR), HER2, and HER4. Learn More
  24. PP2

    Catalog No. A12723
    Quick View
    Src Inhibitor
    PP2 is a selective inhibitor of Src-family tyrosine kinases. Inhibits p56lck and p59fynT (IC50 values are 4 and 5 nM respectively). Displays > 10000-fold selectivity over ZAP-70 and JAK2. Moderately inhibits CSK (IC50 = 0.73 μM). Learn More
  25. Tyrphostin AG 879

    Catalog No. A10053
    Quick View
    HER2 inhibitor
    Tyrphostin AG 879 is an inhibitor of the tyrosine kinase activity of nerve growth factor (NGF) TrkA. Learn More
  26. WHI-P 154

    Catalog No. A14049
    Quick View
    JAK3 inhibitor
    WHI-P 154 is a JAK3 inhibitor with IC50 = 1.8uM. WHI-P 154 also Inhibits STAT1 activation, iNOS expression and NO production in macrophages in vitro. Learn More
  27. WZ3146

    Catalog No. A10990
    Quick View
    EGFR Inhibitor
    WZ3146 is an inhibitor of EGFR receptor kinase mutants carrying a mutation in an active site gatekeeper residue (T790M) and is much less potent against wild-type EGFR kinase. Learn More
  28. WZ4002

    Catalog No. A10991
    Quick View
    EGFR Inhibitor
    WZ4002 is EGFR inhibitor against EGFR T790M (mutation of the gatekeeper T790 residue) which is detected in 50% of clinically resistant patients to gefitinib or erlotinib. Learn More
  29. WZ8040

    Catalog No. A10992
    Quick View
    EGFR Inhibitor
    WZ8040 is a novel EGFR inhibitors that suppress the growth of EGFR-T790M-containing cell lines and inhibit EGFR phosphorylation. Learn More
  30. ZM 39923 HCl

    Catalog No. A13509
    Quick View
    JAK3 inhibitor
    ZM 39923 HCl is an inhibitor of JAK3 (IC50 = 79 nM) that less potently inhibits epidermal growth factor receptor, JAK1, and cyclin-dependent kinase 4 (IC50s = 2.4, 40, and 10 M, respectively) Learn More

30 Item(s)

per page

Set Descending Direction
Rewards